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Abstract
Background: A major effort of the scientific community has been to obtain complete pictures of
the genomes of many organisms. This has been accomplished mainly by annotation of structural and
functional elements in the genome sequence, a process that has been centred in the gene concept
and, as a consequence, biased toward protein coding sequences. Recently, the explosion of
transcriptome data generated and the discovery of many functional non-protein coding RNAs have
painted a more detailed and complex scenario for the genome. Here we analyzed the mouse
carboxypeptidase M locus in this broader perspective in order to define the mouse CPM gene
structure and evaluate the existence of other transcripts from the same genomic region.
Results: Bioinformatic analysis of nucleotide sequences that map to the mouse CPM locus suggests
that, in addition to the mouse CPM mRNA, it expresses at least 33 different transcripts, many of
which seem to be non-coding RNAs. We randomly chose to evaluate experimentally four of these
extra transcripts. They are expressed in a tissue specific manner, indicating that they are not
artefacts or transcriptional noise. Furthermore, one of these four extra transcripts shows
expression patterns that differed considerably from the other ones and from the mouse CPM gene,
suggesting that there may be more than one transcriptional unit in this locus. In addition, we have
confirmed the mouse CPM gene RefSeq sequence by rapid amplification of cDNA ends (RACE) and
directional cloning.
Conclusion: This study supports the recent view that the majority of the genome is transcribed
and that many of the resulting transcripts seem to be non-coding RNAs from introns of genes or
from independent transcriptional units. Although some of the information on the transcriptome of
many organisms may actually be artefacts or transcriptional noise, we argue that it can be
experimentally evaluated and used to find and define biological functional elements on the genome.
Furthermore, the transcription of other functional RNAs besides the protein coding RNA from a
specific genomic locus imposes extra care when designing and interpreting experiments involving
genetic manipulations or expression detection and quantification.
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Background
The carboxypeptidase M (CPM) is a cell membrane metal-
loprotease from the CPN/E regulatory family that is
expressed in varying levels in most cell types [1-3]. It is
believed that this enzyme plays important roles in the
processing of many peptide hormones, especially during
inflammation and macrophage activation [4,5]. Both
CPM activity and protein levels greatly increase in
response to inflammatory stimuli [6,7]. Additionally,
CPM mediated cleavage of the C-terminal arginine from
kinins change their affinity to the kinin B1 and B2 recep-
tors, and this arginine may also be important to NO pro-
duction, especially in the lungs [[6,8], and [9]].
Our group, together with others, have defined experimen-
tally the human CPM gene organization and characterized
that its promoter harbours many cis-regulatory elements
responsive to inflammatory stimulus [10,11]. Although
the same experimental strategy has not been implemented
to resolve the mouse CPM gene [GenBank – GeneID:
70574], it has been defined and annotated on the mouse
chromosome 10 mainly on basis of an in silico analysis of
the mouse transcriptome and genome using the nucle-
otide sequence data on the public databases as well as in
comparison with the human CPM gene sequence.
This new approach to gene definition and genomic anno-
tation is now feasible due to the explosion of nucleotide
sequence data generated by many groups, including
genome and transcriptome projects. However, most of
these genome annotations and transcriptome analysis
have focused on protein coding sequences and have, until
recently, greatly disregarded the amount of non-protein-
coding nucleotide sequences transcribed by the genomes
of eukaryotes [12-14]. Non-protein-coding RNAs seem to
account for a great portion of the transcriptome, for exam-
ple: 34,030 of the 102,281 mouse cDNAs generated by the
FANTOM3 project lack any protein-coding sequence
(CDS) and are annotated as non-protein coding RNA
(ncRNA) [15]; and more than half of the detected tran-
scribed sequences from the human genome regions ana-
lyzed by the ENCODE project are not observed to align
with their annotated protein coding genes [16]. Taking
into consideration this new genome scenario, and in
order to validate the mouse genome annotation for the
CPM gene, we analysed here a number of nucleotide
sequences from various public data banks that map to the
mouse CPM genomic region. These sequences, which
include ESTs and mRNAs of mouse CPM GenBank-Uni-
Gene entry Mm.339332 and cap analysis of gene expres-
sion-tags (CAGE-tags) [17-20] are presented as supporting
evidence for this gene annotation and definition,
although not all of these cDNAs and CAGE-tags have
exactly the same nucleotide sequence as the proposed
CPM gene. In fact, some of these mouse CPM supporting
sequences in the databases have completely different
nucleotide sequences. Therefore, we focused in defining
all possible extra transcripts of the mouse CPM locus on
the basis of these cDNAs and CAGE-tags and their anno-
tation to the mouse CPM genomic locus. We also evalu-
ated experimentally the mouse CPM gene structure and
the expression of some of these proposed extra transcripts
from mouse CPM locus, in addition to the CPM gene in
selected mouse tissues.
Results and discussion
Bioinformatic analysis of the mouse CPM locus and its 
transcripts
The mouse CPM locus is located in the 10D2 region of the
mouse chromosome 10, between the Mdm2 gene (trans-
formed mouse 3T3 cell double minute 2) [GenBank –
Gene ID: 17246] and the annotated mRNA for kinesin-
related protein KIFC5C [GenBank: AF221104], which is a
possible pseudogene of the kinesin family member C1
[GenBank – GeneID: 16580] that maps to the intergenic
region between the Cpsf6 (cleavage and polyadenylation
specific factor 6) [GenBank – GeneID: 432508] and CPM
gene at about 35 kb upstream from the 5'end of the CPM
gene (Figure 1A). We first designated the mouse CPM
gene RefSeq sequence [GenBank: NM_027468] as the
mouse CPM locus Transcript 01 (mCPM-T01). This 5195
nucleotides long sequence is distributed in 9 exons in a
genomic region of about 56 kilobases [21].
In addition to the CPM gene (mCPM-T01), we defined at
least 33 other possible mouse CPM locus  Transcripts
(mCPM-Ts) after analysing a total of 237 sequences that
maps to this locus (Figure 1A): 38 CAGE-tags (see Addi-
tional file 1) and 199 cDNA sequences between mRNAs
and ESTs from the mouse CPM GenBank – UniGene [22]
entry Mm.339332 and other cDNA sequences deposited
in the GenBank (see Additional file 2). Sixteen of these 33
possible mCPM-Ts were defined based only on CAGE-tag
sequences (table 1), and all the information we have
about them is the 18 to 20 initial nucleotides, the direc-
tion of their transcription and the source samples [17-20].
The other 17 mCPM-Ts were defined based on at least one
cDNA sequence, and seven of them are based on cDNAs
of spliced RNAs (mCPM-Ts: 02, 06, 08, 10, 16, 20 and
22). Except for the mCPM T02 and mCPM-T10, all the
other five spliced mCPM-Ts are totally contained in the
mCPM-T01 sequence (Table 1), and may be incomplete
cDNAs from the mCPM-T01. However, three of these five
mCPM-Ts (mCPM-T06, mCPM-T08 and mCPMT16) have
CAGE-tags that map at their beginnings, supporting their
definition as independent transcripts (Figure 1 and table
1). The mouse CPM-T02 shares with mCPM-T01 its two
initial exons but ends on a completely different third exon
located on the second intron of the CPM gene. Thus it is
very likely that its transcription is under control of theBMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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The mouse CPM locus and its transcripts Figure 1
The mouse CPM locus and its transcripts. A) The genomic region on mouse chromosome 10 where the CPM gene maps 
is represented showing the relative position and direction of transcription of the Cpsf6 (in green), CPM (in blue) and Mdm2 (in 
dark blue) genes as well as the pseudogene Kifc5c (in red). B) The analyzed cDNAs and CAGE sequences that support the 
defined mouse CPM locus transcripts are shown in relation to the mouse CPM gene exons. The black vertical lines and blocks 
represent the nucleotide sequences of the cDNA or CAGE-tag(s) in their relative position to the mouse CPM gene exons 
(represented in blue), identified by the cDNA GenBank Accession number (in black) or the CAGE transcription Star Site ID 
(CAGEtss, in blue). The exons of spliced cDNAs are connected by horizontal arrowed lines showing the direction of transcrip-
tion. The mouse CPM locus transcript(s) being supported by these sequences are indicated above the cDNAs and CAGEtss 
codes as "T" and the assigned number, in green when sense, and in red when anti-sense to the CPM gene direction of tran-
scription.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
Page 4 of 14
(page number not for citation purposes)
mouse CPM gene promoter. The mCPM-T10 transcript,
on the other hand, shares the last 3 exons of mCPM-T01,
but it begins at 48 nucleotides upstream of the mouse
CPM gene exon 7 (Figure 1). Furthermore, we have evi-
dence that its expression is controlled by a promoter
region different from that of the mouse CPM gene, as dis-
cussed later.
The other 10 mCPM-Ts defined here on cDNA basis were
all defined from the sequence of non-spliced cDNAs that
map to the mouse CPM locus, and half of them have only
one cDNA sequence that supports their definition (a so
called non-spliced "singleton" cDNA). These non-spliced
singleton sequences are very abundant in many cDNA
databanks and have a high chance of being artefacts such
as DNA contamination, unprocessed pre-mRNA, cloned
spliced-out intronic sequences or simply mistakes of the
transcription machinery (transcription noise) [23]. Four
of these five transcripts defined on the basis of only a sin-
gleton non-spliced cDNA mapped to the anti-sense DNA
strand of the CPM gene (Table 1).
Most of these 33 mouse CPM locus transcripts defined
here seem to be non-coding RNAs. Except for mCPM-T02,
that received a weak coding potential score, all of the
spliced mCPM locus transcripts scored high on the protein
coding analysis using the CPC program (table 1) [24].
However, the high score for the majority of these tran-
Table 1: Mouse CPM locus transcripts defined by bioinformatics analysis
Number of supporting sequences CPC
Transcript DNA strand Total Unique
cDNA
Spliced
cDNA
CAGE Size
(bp)
coding potential score
01 Sense 53# 31 52 3¥ 5195 Strong 6.01
02 Sense 9 3 3 3¥ 798 Weak 0.48
03 Sense 2 2 0 0 391 No -1.28
04 Sense 7 0 ? 7 ? ? ?
05 Sense 2 2 0 0 408 No -1.09
06 * Sense 6 0 3 3 652 Strong 3.70
07 Sense 4 4 0 0 1900 Weak 0.37
08 * Sense 5 0 2 3 1014 Strong 3.52
09 Sense 2 2 0 0 548 No -1.05
10 Sense 7 3 7 0 2007 Strong 1.73
11 Sense 4 4 0 0 1125 No -1.15
12 Sense 1 0 ? 1 ? ? ?
13 Sense 2 0 ? 2 ? ? ?
14 Sense 1 0 ? 1 ? ? ?
15 Sense 1 0 ? 1 ? ? ?
16 * Sense 2 0 1 1 502 Strong 2.68
17 Sense 2 0 ? 2 ? ? ?
18 Sense 1 1 0 0 332 No -1.35
19 Sense 1 0 ? 1 ? ? ?
20 * Sense 4 0 4 0 890 Strong 2.79
21 * Sense 2 0 2 0 547 Strong 1.84
22 * Sense 1 0 ? 1 ? ? ?
23 * Sense 1 0 ? 1 ? ? ?
24 * Sense 2 0 ? 2 ? ? ?
25 * Sense 1 0 ? 1 ? ? ?
26 * Anti-sense 1 0 ? 1 ? ? ?
27 Anti-sense 1 1 0 0 492 Weak 0.02
28 Anti-sense 1 1 0 0 468 No -1.11
29 Anti-sense 1 0 ? 1 ? ? ?
30 Anti-sense 1 0 ? 1 ? ? ?
31 Anti-sense 4 0 ? 4 ? ? ?
32 Anti-sense 1 1 0 0 662 No -1.27
33 Anti-sense 1 0 ? 1 ? ? ?
34 Anti-sense 1 1 0 0 668 No -1.28
Undefined& Both 124 124 0 5 N/A N/A N/A
* Transcripts totally included in the mCPM-T01.
&Non-spliced cDNAs that map in the last exon of mouse CPM gene and probably represent independent transcripts.
#Not including the cDNAs that map to the last exon.
¥ Can be supportive of mCPM-T01 or mCPM-T02.
? = Not enough information to conclude. N/A = not applicable.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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scripts may actually reflect the fact that most of their
sequence is contained in the mouse CPM gene. In fact, the
CPC program takes into account in the calculation of the
coding potential the similarity with known protein
sequences deposited in the UniRef90 databank [24],
which includes the mouse CPM sequence. On the other
hand, all the non-spliced mouse CPM locus  transcripts
scored very low in the CPC program which classified them
as with no coding potential, except for mCPM-T07 and
mCPM-T27, which received a weak protein coding poten-
tial (table 11). In the case of mCPM-T07 this weak coding
potential may also be reasoned because it contains part of
the coding sequence of the CPM gene. As expected, the
highest coding potential score was that of the mCPM-T01,
the mouse CPM gene (table 1).
Finally, there are 124 cDNAs of non-spliced RNAs that
map exclusively to the exon 9 of the CPM gene, support-
ing the existence of other mouse CPM locus transcripts
besides the 33 defined above. However, because we can-
not rule out that they are incomplete cDNAs from some of
the already defined mCPM-Ts, we defined only 4 tran-
scripts there based on 5 CAGE-tags that map to this
genomic region (Figure 1, mCPM-Ts: 22 to 25). Further-
more, it is still very intriguing that several independent,
mainly non-coding, RNA transcripts come from the
sequences of the last exon of the genes [25,26]. This seems
to be very frequent in genes in the so called genomic head
to tail orientation, where a gene is in close proximity to
opposite DNA strand neighbours, and these last exons
transcripts are suggested to play regulatory roles [15,27].
Experimental analysis of the mouse CPM locus transcript 
01, the mouse CPM gene
From the 237 sequences analysed, there are 31 cDNAs
whose sequences are totally included in the mouse CPM
RefSeq nucleotides and therefore cannot be attributed to
any other transcript in the locus besides the mCPM-T01
(table 1). The mCPM-T01 sequence coding for mouse
CPM protein, a 443 amino acids polypeptide that shares
about 84% similarity with the human CPM protein,
begins in the second exon and extends to the beginning of
the last exon – the exon 9 (Figure 2A). This mCPM-T01
coding region was confirmed by RT-PCR, cloning and
sequencing (Figure 2B).
We also obtained for the start of transcription of mCPM-
T01 the same initial nucleotides of the mouse CPM gene
RefSeq sequence in RACE 5'experiments using an anti-
sense primer directed to the beginning of the mouse CPM
exon 3 (Figure 2C and Additional file 3), besides confirm-
ing the splicing junctions of exons 1, 2 and 3. These 5'
RACE experiments did not confirm a possible start of tran-
scription 74 nucleotides upstream of this point, sup-
ported by 3 CAGE-tags in the sense orientation [CAGE TSS
ID: T10F06FFD6E7] (Figure 2C). Furthermore, none of
the 199 cDNAs analysed here were found to begin
upstream of the 5'RACE confirmed start site. Out of the 30
cDNAs that map their beginning to the initial region of
the CPM gene, 16 share the same start as the mouse CPM
RefSeq sequence and the other 14 begin 1 to 15 nucle-
otides downstream of this start site (see Additional file 4).
However, we cannot rule out the possibility that these 3
CAGE-tags that map upstream of the mCPM-T01 start
may actually be the beginning of the mCPM-T02 tran-
script, or that they are tissue specific, since we did not test
the same tissues that originated these CAGE-tags nor per-
formed 5'RACE experiments with mCPM-T02 specific
primer.
There are eight classical poly-A signals located at the 3'end
of the mouse CPM locus that could be used to process the
3'end of the mCPM-T01 mRNA (genomic sequence
AATAAA), which we designated poly-A signal 1 to 8 (PA 1
to 8) (figure 2A and Additional file 5). This genomic
region extends from the mouse CPM RefSeq last exon into
the intergenic region between the end of this exon and the
end of the Mdm2 gene last exon. We could not find any
individual cDNA on the GenBank [28] that extended
through the entire sequence of the mouse CPM RefSeq or
that extended further than the third poly-A signal cleavage
site when having all the exons. This can be easily
explained by the existence of adenosine rich stretches in
the last exon of the mouse CPM RefSeq that could func-
tion as an internal annealing site to the oligo dTs used in
the construction of the cDNA libraries [23](see Additional
file 5).
Analysis by 3'RACE experiments confirmed the use of the
third classical poly-A signal in this region (PA3), located
at nucleotide 2723 of the mouse CPM RefSeq sequence
[GenBank: NM_027468] (Figure 2D). We also obtained
in the 3'RACE experiments one clone of the 3'end of the
possible CPM mRNA that ended exactly after the fourth
poly-adenosine signal (PA4) in a stretch of poly-adenos-
ines also present in the corresponding genomic sequence
beginning at nucleotide 3146 of the CPM RefSeq
sequence. Therefore, we cannot exclude that this clone
was the result of internal annealing of the oligo dT 3'RACE
adapter to longer mRNAs (Figure 2D and Additional file
5). In addition, we obtained by long-range RT-PCR cDNA
fragments that supported the use of poly-A signals 4, 5
and 6, but we were unable to obtain fragments that evi-
denced the use of the two most downstream poly-A sig-
nals in the 3'end of the mouse CPM locus, PA7 and 8
(Figure 2E).
Northern blot analysis of total RNA from 5 different
mouse samples and a probe that anneals to the exons 8
and 9 of the mouse CPM mRNA detected three major
RNAs that appear to be 2.8 kb, 3.0 kb and 5.2 kb long (Fig-
ure 2F), which are in accordance with the use of poly-ABMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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signals 3, 4, 5 or 6 with the addition of a 80 to 90 nucle-
otide long mature poly-A tail [29,30].
Together, these results confirm the RefSeq sequence of the
mouse CPM as the longest possible mouse CPM locus tran-
script, the mCPM-T01, but also indicate that at least two
smaller mRNAs for the mouse CPM protein are tran-
scribed from the mouse CPM gene varying mainly in the
size of their 3'untranslated end.
Detecting other mouse CPM locus transcripts in mouse 
tissues
We randomly chose to check by RT-PCR the existence of
RNAs from four of the possible mouse CPM locus tran-
scripts. We defined these locus transcripts by bioinformat-
ics analysis based on more than one cDNA sequence, and
they are: mCPM-T03, mCPM-T07, mCPM-T09 and
mCPM-T10. We were able to amplify by RT-PCRs the
expected cDNA fragments from all these four possible
mouse CPM locus transcripts in almost all tested mouse
samples, confirming their existence (Figure 3). We also
confirmed the sequence of the RT-PCR amplicons by clon-
ing and sequencing the DNA fragments of the expected
sizes obtained in previously performed experiments (data
not shown).
Quantitative RT-PCR analysis in mouse tissues of five CPM 
locus Transcripts
To validate the expression of mouse CPM locus transcripts
03, 07, 09 and 10 and rule out that they were the result of
The mouse CPM gene Figure 2
The mouse CPM gene. (A) Representation of the mouse CPM gene, mRNA and protein showing the exons as numbered 
blocks, the untranslated and the coding regions in yellow and blue respectively, and the poly-A signals (PA1 to 8) as red lines. 
The dark blue block represents the Mdm2 gene last exon. (B) The cDNA fragments for the mouse CPM gene coding region 
obtained in two independent RT-PCRs. (C) Genomic DNA sequence of the 5'end of the mouse CPM gene indicating the posi-
tions of the CPM exon 1 (yellow block), three sense CAGE-tags (green arrow) and one anti-sense CAGE-tag (red arrow). (D) 
The 3'RACE PCRs from: adult mouse lung (1), 14 day embryo (2), 14 day placenta (3) and no template as negative control (0). 
(E) Long range RT-PCRs to evaluate the use of mouse CPM Poly-A signals 2 to 8. (F) Mouse CPM specific northern blot of total 
RNA from: 14 day embryo RNA (1), 14 day placenta RNA (2), 14 day embryo red organs (3), 18 day placenta (4) and 18 day 
embryo red organs (5). The position of the ribosomal RNAs 28S and 18S are indicated as blue dots, and the approximated size 
of the visualized bands in number of nucleotides are shown at right in black. The RT-PCRs and 3'RACE results shown here are 
negative images of UV light visualized 1% agarose gel electrophoresis stained with ethidium bromide, and M indicates the DNA 
size standards with some of their DNA fragments size shown as base pairs.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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transcription noise we analysed the level of expression by
quantitative RT-PCR of each of these mCPM-Ts and the
mouse CPM gene (mCPM-T01) relative to the expression
of the housekeeping gene TBP in three independent sam-
ples of 6 mouse adult organs, in 14 day embryos and pla-
centas (Figure 4 and table 2).
As expected, the highest expression detected was that of
the mouse CPM gene (mCPM-T01) in lungs, where it was
almost three times the TBP expression (Figure 4A and
table 2).
The mCPM-T01 relative expression in any particular tissue
or in the embryos or placentas did not differ in each of the
three independent samples of the same kind, as shown by
the low coefficient of variation (CV) of the mean relative
expression calculated from the results of three independ-
ent samples (Table 2). This was also the case for the other
four mouse CPM locus transcripts quantified, demonstrat-
ing that they possess a tissue specific level of expression
that does not vary between similar individuals (Table 2).
These results indicate that these extra four CPM locus tran-
scripts are not the result of transcriptional noise, since one
would expect values of expression with greater variability
even between the same types of samples of different ani-
mals because of the random nature of such phenomenon.
The mCPM-T03, mCPM-T07 and mCPM-T09 patterns of
expression in the various tissues were very similar to that
of the CPM gene (with p < 0.001 significant Pearson cor-
relation coefficients of respectively: 0.92, 0.93 and 0.96),
which suggests that they may be part of the same tran-
scriptional unit, and therefore be under the same tran-
scriptional regulatory control. The only small divergence
from the mouse CPM gene expression was that the expres-
sion of these mCPM-Ts in spleen was comparable to their
expression in kidney (Figure 4F).
The mCPM-T03 and 09 map to intronic regions of the
mouse CPM gene, and may well be processed spliced-out
intronic RNAs from the mouse CPM pre-mRNA, which
could explain the same expression pattern. These tran-
scripts may still be functional non-coding RNAs under the
same transcriptional control as the CPM gene and part of
the regulatory RNA network [13,14].
On the other hand, the similarity of the expression pat-
terns of mCPM-T07 and the mouse CPM gene cannot be
explained in the same way as the patterns of mCPM-T03
and mCPM-T09 expressions, since this non-spliced tran-
script includes in its sequence the entire mouse CPM gene
exon 5 and extends at least for other 800 nucleotides in
both introns 4 and 5 (see Additional file 6). However, we
cannot rule out the possibility that the mCPM-T07 meas-
ured expression is in reality detection of the mouse CPM
pre-mRNA. Further investigation is needed to exclude this
possibility and validate mCPM-T07 as a real transcript.
The mCPM-T10 is the only of the four extra mouse CPM
locus transcripts evaluated that is processed into a spliced
RNA. It is expressed in all samples tested in a much lower
level than the mouse CPM gene (mCPM-T01) or the other
three extra transcripts evaluated (Figure 4E and Table 2).
Additionally, the mCPM-T10 presented an expression pat-
tern that differed considerably from the other mCPM-Ts
Detecting other mouse CPM locus transcripts Figure 3
Detecting other mouse CPM locus transcripts. Nega-
tive images of 2% agarose gels stained with ethidium bromide 
and visualized under UV light after electrophoresis of the fol-
lowing reactions: (A) PCRs confirming the good quality of the 
reversed transcribed RNAs of the indicated mouse samples 
by detecting the expected TBP gene transcript fragment. (B) 
PCRs using as template the same reversed transcribed RNAs 
of the indicated mouse samples used in the previously panel 
(RT+) or their no reverse transcriptase control reactions 
(RT-) to detect the mouse CPM locus transcripts 03, 07 and 
09. (C) PCRs to detect the mouse CPM locus transcript 10 in 
the reversed transcribed RNAs of the indicated mouse sam-
ples. No template PCRs for all experiments are indicated. 
The DNA ladder marker ϕX174RF DNA/Hae III fragments 
(Invitrogen) was used in all gels and the size of the lowest 
four bands in base pairs are indicated. Control PCRs using as 
template the respective no reverse transcriptase reaction for 
each mouse sample (RT-) were performed to confirm no 
amplification from genomic DNA contamination only for the 
mCPM-T03, 07 and 09 because designed primers anneal to 
the same exon of the targeted transcripts.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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evaluated and from the mouse CPM gene (Figure 4F),
with no significant correlation (p > 0.5 for all compari-
sons, and coefficients of correlation with the expression
pattern of the other analysed mCPM-Ts ranging from -
0.02 to 0.08). This indicates an independent control of
transcription from the mouse CPM gene for this tran-
script, and suggests the existence of other transcriptional
units in the locus.
It is also very interesting that the bioinformatic defined
sequence of the mCPM-T10 transcript carries a coding
region for a protein with 195 amino acids that differs only
in its seven initial N-terminal amino acids from the C ter-
minal sequence of the mouse CPM protein. This hypo-
thetical protein, if translated from the mCPM-T10 RNA,
would include the C terminal glycosylphosphatidylinosi-
tol anchor (GPI anchor) site and part of the catalytic
domain, which would very unlikely fold in a similar way
as in the full length mouse CPM protein. Whether mCPM-
T10 is an authentic coding or non-coding transcript still
awaits further investigation.
Conclusion
These results support the recent view that the majority of
the genome sequence is transcribed, and that many of the
resulting transcripts seem to be non-coding RNAs exerting
many different cellular functions. The existence of these
extra transcripts can be deduced from the information on
the transcriptomes deposited in the various public data
banks, even though part of this information may actually
be artefacts or transcriptional noise. However, we argue
that we can still reliably use this information to find and
define biological functional elements on the genome in
addition to protein coding genes, but they have to be care-
fully experimentally validated.
The existence of multiple transcripts from the same tran-
scriptional unit greatly enhances the possibility of genetic
interactions between different genomic loci and gives sup-
port to the notion of a regulatory network based on RNAs
[13,14]. Furthermore, our results also support the view
that a specific genomic region may harbour independent
transcriptional units.
The existence of both, unknown transcripts being made
from a transcriptional unit of a locus or unknown inde-
pendent transcriptional units in the same locus, is espe-
cially important in interpreting the results of genetic
manipulations such as transgenic and knockout models as
well as genetic screening studies, since the observed phe-
notype variation may actually be resulting from unpre-
dicted disturbances on them. And finally, expression
detection and quantification studies have to take into
account the existence of extra transcripts in the same target
region when designing the experiments, at the risk of
obtaining misleading measurements.
Methods
Bioinformatic analysis
We defined the possible mouse CPM locus  transcripts
(mCPM-Ts) by analysing the cDNAs and CAGE-tag
sequences that mapped to the genomic sequence locus
using the Blat and genome browser tools of the USCS
Genome Browser Database [31-33] as well as the BlastN
tools of the NCBI [22,34]. The coding potential of the
defined mCPM-Ts was evaluated using the CPC program
[24]. The comparison between the mouse and human
CPM protein was made using the BlastP tool on the NCBI
[22,34].
Animals and sampling
All animals used in this study were C57Bl/6 mice 3 to 4
month old from the Centro de Desenvolvimento de Mod-
elos Experimentais para a Medicina e Biologia of the Fed-
eral University of São Paulo, where they were maintained
on standard mouse chow at 22°C on 12 h light-dark cycle
allowed ad libitum access to food and tap water. All exper-
iments reported have been conducted as stated in the NIH
guide for the care and use of laboratory animals [35] and
approved by a local animal care and use committee [Pro-
tocol: 2007111494137]. Embryos and placentas were col-
lected from 8, 14 and 18 day pregnant female mice, and
all the other tissues from male mice. Mouse resident peri-
toneal cells (MPCs) were obtained by centrifugation for 3
minutes at 300 g of a 2 ml per animal of cold PBS injected
intraperitoneally and subsequently collected from the
peritoneal cavity of four CO2 sacrificed males. The sam-
ples were either immediately processed to obtain the total
RNA in TRIzol reagent or frozen in liquid nitrogen and
stored at -80°C for future use.
RNA extraction
Total RNA from samples collected in TRIzol reagent were
isolated as instructed by the manufacturer, and resus-
pended in Milli-Q academic system (Millipore) purified
water. The RNAs concentrations were measured with the
NanoDrop 1000 (Thermo scientific) instrument and their
integrity was confirmed by visualizing under a UV illumi-
nation the rRNAs bands after electrophoresis of 1 μg of
total RNA/per sample in a 1% agarose Gel stained with
ethidium bromide.
RT-PCR and Long Range RT-PCR
We obtained total cDNA for each sample with the M-MLV
Reverse Transcriptase (Invitrogen) from 5 μg of the respec-
tive purified total RNA after treating it with RQ1 RNAse-
Free DNAse (Promega), using these products suggested
protocols. We also obtained a negative control reverse
transcription reaction in parallel for each sample using theBMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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Expression analysis of some mouse CPM locus transcripts Figure 4
Expression analysis of some mouse CPM locus transcripts. The level of expression in mouse organs and embryos of 
five mouse CPM locus transcripts (mCPM-Ts) is shown in panels A to E. The expression levels of mCPM-Ts were calculated as 
the mean relative expression value of three independent samples and presented as percentage of the respective mean TBP 
gene expression on these three samples. A comparison of the analysed mCPM-Ts pattern of expression in the indicated mouse 
organs and embryo is presented as a percentage of the highest relative expression in panel F.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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same protocol above but omitting the reverse tran-
scriptase in order to test for genomic DNA contamination
on the total RNAs. For each RT subsequent PCR we used 5
μl of a 1/50 diluted total cDNA or respective negative con-
trol reverse transcriptase reaction as template in a 50 μl
final volume reaction as follows.
i) To obtain the two mouse CPM coding cDNA fragments
of figure 2B we used an equal amount mixture of the 1/50
diluted lung total cDNAs from 3 animals as template, the
forward and reverse primers pmCPM2f2 + pmCPM9r3 for
reaction 1 and pmCPM2f3 + pmCPM9r2 for reaction 2,
and the Platinum Taq DNA Polymerase High Fidelity
(Invitrogen) as suggested by the manufacturer with the
temperature protocol: 94°C for 3 min, 35 cycles of a dena-
turing step of 94°C for 15 seconds, a primer annealing
step of 60°C for 30 seconds and an extension step of 68°C
for 1.5 minutes.
ii) The long range RT-PCR reactions were performed with
the Elongase Amplification System (Invitrogen) as sug-
gested by the manufacturer, using a similar temperature
protocol as above, except that the extension step duration
varied depending on the reverse primer used with the for-
ward primer pmCPMe8f, as follows: pmCPMpa2 for 1.5
minutes, pmCPMpa3 for 2 minutes, pmCPMpa4 for 2.5
minutes, pmCPMpa5 for 5 minutes, pmCPMpa6 for 5
minutes, pmCPMpa7 for 7 minutes and pmCPMpa8 for 7
minutes. as templates either: The same lung total cDNA,
the respective control reverse transcriptase reaction (with-
out the enzyme) and Milli-Q purified water was used as
templates for the PCRs as indicated in figure 2D.
iii) To detect by RT-PCR the mCPM-Ts and the TBP expres-
sion shown on figure 3 we used the TAQ DNA polymerase
(Invitrogen) as suggested by the manufacturer with
cycling temperatures protocol of: 94°C for 3 min; 3 cycles
of 94°C for 15 seconds and 72°C for 30 seconds; 3 cycles
of 94°C for 15 seconds, 65°C for 15 seconds and 72°C
for 30 seconds; 3 cycles of 94°C for 15 seconds, 63°C for
15 seconds and 72°C for 30 seconds; 30 cycles of 94°C
for 15 seconds, 60°C for 30 seconds and 72°C for 30 sec-
onds. We also used as templates for these PCRs 1/50
diluted total cDNA of each indicated sample and as nega-
tive control the respective negative control reverse tran-
scription reaction (indicated as RT-); and the forward and
reverse primers pairs: pTBPf+ pTBPr for the TBP gene,
pmCPMt03f + pmCPMt03r for mCPM-T03, pmCPMt07f
+ pmCPMt07r for mCPM-T07, pmCPMt09f +
pmCPMt09r for mCPM-T09 and pmCPMt10f +
pmCPMt10r for mCPM-T10. We also performed PCRs
with no template for all the primer sets. Because the frag-
ments amplified by the TBP gene and mCPM-T10 primers
pairs from cDNA extends through exon-exon junctions,
only the no template PCRs were performed as control. The
sequence of all oligonucleotides used as primers are pre-
sented in Additional file 7.
The DNA ladder markers ϕX174RF DNA/Hae III frag-
ments and λDNA/Hind III fragments (Invitrogen) where
used, either together or separately, as DNA size standards
in all agarose gel electrophoresis performed.
Cloning and sequencing
All the RT-PCR DNA fragments that were cloned here were
first collected from ethidium bromide stained agarose gel
after electrophoresis and purified with the Qiaex II gel
purification kit (Qiagen), subsequently individually
cloned into the pGemT-Easy vector system (Promega),
transformed into the E. Coli DH5α strain (Invitrogen),
selected and amplified following the manufacturer's
instructions. The purification of each plasmidial DNA was
carried out as described by Sambrook J et al. [36]. Both
DNA strands of each plasmid were sequenced using the
BigDye Terminators Kit (Applied Biosystems) on the auto-
mated ABI 377 sequencer (Applied Biosystems) and 500
ng of purified plasmid DNA with 3.2 picomoles of either
M13 forward or reverse primers as suggested by the man-
ufacturer.
Table 2: The relative expression of some of the mouse CPM locus transcripts
mCPM-T01 mCPM-T03 mCPM-T07 mCPM-T09 mCPM-T10
Sample Mean CV (%) Mean CV (%) Mean CV (%) Mean CV (%) Mean CV (%)
Heart 61.2 32.6 11.8 7.0 1.9 24.1 2.9 2.8 0.048 39.8
Liver 18.1 55.7 2.1 34.4 0.7 26.8 1.2 17.4 0.002 39.1
Lung 2 7 5 . 2 2 4 . 64 3 . 91 5 . 31 4 . 12 3 . 31 6 . 92 3 . 3 0 . 0 9 6 3 3 . 5
Kidney 117.9 2.0 14.5 10.3 4.5 1.6 5.5 9.3 0.022 12.4
Brain 47.8 24.0 6.7 3.2 1.6 5.4 3.3 12.2 0.272 10.2
Spleen 43.4 17.8 16.6 24.4 5.1 26.5 4.3 22.4 0.079 34.8
Placenta 57.5 10.3 3.7 20.1 0.6 17.6 1.1 23.8 0.005 47.0
Embryo 54.5 21.8 6.6 11.2 1.1 4.3 1.7 17.7 0.151 34.4
The mean relative expression evaluated by qRT-PCR of the indicated mouse CPM locus transcripts in different mouse organs and 14 day gestation 
Embryo, expressed as percentage of the respective mean TBP gene expression. All values are calculated from individual values of relative 
expression of three animals for each sample and their coefficient of variation (CV) is presented as percentage of the mean value.BMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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5'and 3'RACE experiments
To define the beginning and the end of the mouse CPM
mRNA we used the FirstChoice RLM-RACE kit (Ambion)
with the Platinum TAQ DNA polymerase (Invitrogen) for
the PCRs in the 5'RACE experiments and the Elongase
Amplification System (Invitrogen) for the 3'RACE ones.
We essentially followed the protocols suggested by the
manufacturers, except that in the 5'RACE experiments the
RNAs were purified from the CIP reactions using 250 μl of
TRIzol (Invitrogen) and the reverse transcriptions were
performed with the mouse CPM specific primer
pmCPM9r3. Each outer 5'RLM-RACE reaction was done
using the primer pmCPMe4r as a 5'RACE gene-specific
outer primer and 2 μl of a reverse transcribed previously
treated total RNA from 8 day mouse embryos and pla-
centa (EP), 14 day embryos (E) and placenta (P), 3 to 4
month old adult male lungs (L) and adult male peritoneal
residing cells (C). Then, 2 μl of these reactions were used
as templates in nested inner 5'RLM-RACE reactions with
the primer pmCPMe3r as the 5'RACE gene-specific inner
primer. Only the outer 3'RLM-RACE reactions were done
to define the 3'mouse CPM ends, performed with the
primer pmCPMe8f as the 3'RLM-RACE gene specific outer
primer and as template the total cDNAs from total RNA of
adult mouse lung, and 14 day embryos and placentas. The
resulting amplified products of the 5'and 3'RACE reac-
tions were purified after agarose gel electrophoresis using
the Qiaex II gel extraction kit (Qiagen), cloned into
pGemT-Easy vector (Promega) and sequenced.
Northern blot
Approximately 30 μg of purified total RNA from the indi-
cated samples were used to prepare a Hybond-N+ nylon
membrane (Amersham) blot after electrophoresis in a 1%
agarose gel, and hybridized to a phosphorus 32 labelled
mouse CPM anti-sense ssDNA probe essentially as
described by Brown and colleagues [37], except that we
only checked the RNA and Transfer quality by Methylene
Blue staining the blot previously to hybridizing, and the
mouse CPM probe was prepared by a labelling PCR. This
labelling PCR was carried out in a final volume of 50 μl
using as template approximately 15 ng of a DNA fragment
corresponding to the nucleotide sequence 1153 to 1350
of mouse CPM RefSeq sequence [GenBank: NM_027468],
that was obtained from the pGemT-Easy vector (Promega)
containing the previously subcloned and sequenced DNA
fragment of the RT-PCR with primer pairs pmCPM2f3 +
pmCPM9r2, after Eco RI/Himd 3 endonuclease digestion
and a 2% agarose gel electrophoresis with Qiaex II Gel
Extraction Kit (Qiagen). This PCR was performed with the
TAQ recombinant DNA polymerase (Invitrogen) as sug-
gested by the manufacturer except that only the anti-sense
primer mCPM9r2 was added at a final concentration of 1
μM, and 1 μl of [γ-32P]dCTP (6000 Ci/mmol, ≥ 10 mCi/
ml) (Amersham) was used instead of the suggested 5 mM
dCTP. The PCR temperature protocol was of 94°C for 3
min, followed by 40 cycles of 94°C for 15 seconds, 55°C
for 30 seconds and 72°C for 30 seconds, and ended at
4°C. The probe was cleaned from unincorporated nucle-
otides using the ProbeQuant tm G-50 Micro Columns
(Amersham Biosciences) as instructed by the manufac-
turer. The hybridized blot was exposed to a phosphor
imaging screen for 24 hours and analyzed by the Cyclone
Phosphoimager System (Perkin Elmer).
Quantitative RT-PCR (qRT-PCR)
All reactions were done in triplicate using 5 μl of the sam-
ples' total cDNA diluted 1/50, 10 μl of the Power SYBR
Green PCR Master Mix (Applied Biosystems), 1 μl of the
transcripts specific primer pairs used in the previously
described RT-PCRs, the TBP gene specific primer pair
pTPBf + pTBPr or the mouse CPM gene specific primers
pair pmCPMf + pmCPMr (all primer mixtures with 10
mM of each primer) in a final volume of 20 μl in the 7000
Sequence Detection System (Applied Biosystems) with a
temperature cycling of: 50°C for 2 minutes, 95°C for 10
minutes, 40 cycles of 95°C for 15 seconds and 60°C for
30 seconds followed by the dissociation curve standard
protocol. For each reaction a value of Cq (cycle of quanti-
fication) was obtained in the exponential phase of the
PCRs' kinetic curve.
We first performed qPCR runs in duplicate using as tem-
plate a serial dilution of the pGemT-Easy vector with each
transcript expected amplicom (previously cloned and
sequenced) to evaluate the TM of the expected dissocia-
tion curve peak and the sensitivity of the reactions. After
confirming the expected single peak in the dissociation
curve and obtaining a Cq value for each sample's reaction
we calculated the average efficiency of the qPCR for each
primer pair using the efficiency of each reaction calculated
with the LinRegPCR program [38]. We then calculated the
relative expression ratio for each transcript in relation to
the TBP expression with the equation:
RmCPM-T/TBP(%) = [(ETBP)CqTBP/(EmCPM-T)CqmCPM-T] × 100;
were "RmCPM-T/TBP(%)" is the average relative expression of
the analyzed transcript in a sample presented as percent-
age of the average expression of the TBP gene in that sam-
ple, "ETBP" is the average efficiency of all the samples' TBP
reactions, "CqTBP" is the average Cq value between the
triplicated TBP reactions for the specific sample being ana-
lyzed, "EmCPM-T" is the average efficiency of all the sam-
ples' reactions for the mouse CPM locus transcript being
analyzed and "CqmCPM-T" is the average Cq value
between the triplicate reactions of the same mouse CPM
locus transcript in question for the analyzed sample.
The average Cq values between the specific triplicate reac-
tions had standard deviations lower than the recom-
mended limit of 0.3 cycles, except four values that hadBMC Molecular Biology 2009, 10:7 http://www.biomedcentral.com/1471-2199/10/7
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standard deviation between 0.3 and 0.5 cycle, but these
were Cqs above 30 cycles, where these degrees of standard
deviation are acceptable [39-41].
Statistical analysis
Unless otherwise indicated, the data are expressed as
mean ± SEM. The analysis of the Pearson correlation coef-
ficients was done with the GraphPad Prism software
(GraphPad Software Incorporated) using the mean value
of relative expression shown on table 2.
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